Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Hunkering down on deals and racial diversity pledge amid pandemic, Giovanni Caforio took home $20M last year at Bristol Myers Squibb
5 years ago
Moncef Slaoui offers his 'deep regret' over sexual harassment charge — while getting the boot from biotech posts
5 years ago
Merck's big C-suite shuffle continues as Caroline Litchfield is tapped as new CFO
5 years ago
GlaxoSmithKline fires Moncef Slaoui as Galvani chair after ongoing probe substantiates sexual harassment allegations
5 years ago
One of the masterminds behind remdesivir, Gilead's Diana Brainard jumps ship to antiviral T cell player AlloVir
5 years ago
FDA's No. 2 Amy Abernethy to leave the agency in April
5 years ago
FDA+
José Baselga, acclaimed drug hunter, physician and AstraZeneca's pioneering cancer R&D chief, has died
5 years ago
Founders of poop-testing uBiome, reportedly on the run, charged by SEC with defrauding investors
5 years ago
Christopher Austin makes his return to industry, jumping ship from NIH over to CEO-partner role at Flagship
5 years ago
Drugmakers brace for a pricing fight as Xavier Becerra is confirmed as the next HHS secretary
5 years ago
Pharma
Denied top job, Mike Nally exits chief marketing job at Merck as the big C-suite shakeup continues
5 years ago
A departing CMO pens a sad farewell as he heads back to the UK biopharma scene
5 years ago
Bioregnum
Opinion
After a roller coaster ride, Sage COO strikes out on his own to chart a new biotech path
5 years ago
Another bluebird exec jumps ship as questions swirl over gene therapies and imminent split
5 years ago
Cell/Gene Tx
Fresh out of the bluebird bio oncology split, Joanne Smith-Farrell flies the coop to Be Bio and its B cell platform
5 years ago
Cell/Gene Tx
BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines
5 years ago
Pharma
Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies
5 years ago
Deals
Albert Bourla bagged $21M in year marked by generics spinoff, colossal R&D effort for Covid-19 vaccine
5 years ago
Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D
5 years ago
CFO departs Intercept as trickle becomes mass exodus from NASH biotech
5 years ago
With profits lagging, Emma Walmsley, Big Pharma's only woman CEO, may once again be its lowest paid
5 years ago
Pharma
Eli Lilly promotes Edgardo Hernandez to head its manufacturing operations as 19-year vet O'Neill hits the exit
5 years ago
Manufacturing
Exclusive: Former Intercept CMO lands new gig at Q32 Bio, two weeks after leaving the NASH biotech
5 years ago
Martin Shkreli faces another lawsuit, this time from insurer, alleging plans to create a monopoly for Daraprim
5 years ago
First page
Previous page
59
60
61
62
63
64
65
Next page
Last page